Gene · 406934
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. | Int J Mol Sci | 2023 | 37511303 | PubTator, text mining | PubMed |
| Correlation of TIMP1-MMP2/MMP9 Gene Expression Axis Changes with Treatment Efficacy and Survival of NSCLC Patients. | Biomedicines | 2023 | 37509417 | PubTator, text mining | PubMed |
| Super-enhancers complexes zoom in transcription in cancer. | J Exp Clin Cancer Res | 2023 | 37501079 | PubTator, text mining | PubMed |
| Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort. | Sci Rep | 2023 | 37491482 | PubTator, text mining | PubMed |
| Finding the priority and cluster of inflammatory biomarkers for infectious preterm birth: a systematic review. | J Inflamm (Lond) | 2023 | 37488605 | PubTator, text mining | PubMed |
| Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway. | Breast Cancer Res | 2023 | 37461019 | PubTator, text mining | PubMed |
| Role of salivary miRNAs in the diagnosis of gastrointestinal disorders: a mini-review of available evidence. | Front Genet | 2023 | 37456668 | PubTator, text mining | PubMed |
| Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | 37446039 | PubTator, text mining | PubMed |
| Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention. | Int J Mol Sci | 2023 | 37445956 | PubTator, text mining | PubMed |
| Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Int J Mol Sci | 2023 | 37445763 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer. | Cancers (Basel) | 2023 | 37444595 | PubTator, text mining | PubMed |
| Role of miRNAs in Rheumatoid Arthritis Therapy. | Cells | 2023 | 37443783 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665-HMGB1 axis. | J Gastrointest Oncol | 2023 | 37435216 | PubTator, text mining | PubMed |
| Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. | Cancer Manag Res | 2023 | 37426392 | PubTator, text mining | PubMed |
| Advancements in understanding the role of microRnas in regulating macrophage polarization during acute lung injury. | Cell Cycle | 2023 | 37415386 | PubTator, text mining | PubMed |
| MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling. | Cell Signal | 2023 | 37406787 | PubTator, text mining | PubMed |
| Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma. | Front Oncol | 2023 | 37404761 | PubTator, text mining | PubMed |
| PAX5-miR-142 feedback loop promotes breast cancer proliferation by regulating DNMT1 and ZEB1. | Mol Med | 2023 | 37403081 | PubTator, text mining | PubMed |
| Biomodified Extracellular Vesicles Remodel the Intestinal Microenvironment to Overcome Radiation Enteritis. | ACS Nano | 2023 | 37399352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406934/papers?page=10